Scpharmaceuticals Stock Today

SCPH Stock  USD 4.53  0.07  1.52%   


0 of 100

Very Weak

Odds Of Distress

Over 84

Very High
Scpharmaceuticals is trading at 4.53 as of the 14th of July 2024. This is a 1.52 percent decrease since the beginning of the trading day. The stock's open price was 4.6. Scpharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Scpharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 16th of January 2024 and ending today, the 14th of July 2024. Click here to learn more.
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. The company has 36.05 M outstanding shares of which 5.83 M shares are at this time shorted by private and institutional investors with about 24.04 trading days to cover. More on Scpharmaceuticals

Moving against Scpharmaceuticals Stock

  0.59DRRX DurectPairCorr
  0.38DNLI Denali TherapeuticsPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Scpharmaceuticals Stock Highlights

President CEO, DirectorJohn Tucker
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors)
Financial Strength
Scpharmaceuticals (SCPH) is traded on NASDAQ Exchange in USA. It is located in 25 Mall Road, Burlington, MA, United States, 01803 and employs 135 people. Scpharmaceuticals is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 163.33 M. Scpharmaceuticals conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 36.05 M outstanding shares of which 5.83 M shares are at this time shorted by private and institutional investors with about 24.04 trading days to cover. Scpharmaceuticals currently holds about 55.85 M in cash with (59.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.04.
Check Scpharmaceuticals Probability Of Bankruptcy
Ownership Allocation
The majority of Scpharmaceuticals outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Scpharmaceuticals to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Scpharmaceuticals. Please pay attention to any change in the institutional holdings of Scpharmaceuticals as this could imply that something significant has changed or is about to change at the company.
Check Scpharmaceuticals Ownership Details

Scpharmaceuticals Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Scpharmaceuticals market risk premium is the additional return an investor will receive from holding Scpharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Scpharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Scpharmaceuticals' alpha and beta are two of the key measurements used to evaluate Scpharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.

Scpharmaceuticals Stock Against Markets

Scpharmaceuticals Corporate Management

John PharmDSenior AffairsProfile
Rachael NokesPrincipal Accounting OfficerProfile
Katherine TaudvinDirector RelationsProfile
Michael HassmanSenior OperationsProfile
Steve ParsonsSenior CommercialProfile

Additional Information and Resources on Investing in Scpharmaceuticals Stock

When determining whether Scpharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Scpharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Scpharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Scpharmaceuticals Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Scpharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in Scpharmaceuticals Stock please use our How to Invest in Scpharmaceuticals guide.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scpharmaceuticals. If investors know Scpharmaceuticals will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Scpharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Scpharmaceuticals is measured differently than its book value, which is the value of Scpharmaceuticals that is recorded on the company's balance sheet. Investors also form their own opinion of Scpharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Scpharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Scpharmaceuticals' market value can be influenced by many factors that don't directly affect Scpharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Scpharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Scpharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Scpharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.